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Peritoneum is a site for both primary and secondary tumors. Primary peritoneal clear cell carcinoma (PPCC) is very rare and very few cases have been reported till date [1]. With 
its histomorphological resemblance to malignant mesothelioma, 
serous carcinoma, metastatic adenocarcinoma and clear cell 
carcinoma, it is a great diagnostic challenge to the pathologists. 
Further due to paucity of the information available on biological 
behavior, pathogenesis, and management plan and treatment 
outcome, it remains a clinical challenge yet to be explored. We 
report a case of PPCC to add to the existing knowledge on the 
clinicopathological feature of this rare tumor.
CASE REPORT
A 55-year-old female presented with non-specific pain in the lower 
abdomen for 1 month. She was a known case of hypothyroidism 
on a regular dose of 100 mg thyroxin once a day. There was no 
other significant present or past history. On examination, she was 
conscious, oriented with stable vitals, and unremarkable general 
examination findings. Per abdomen examination revealed a hard, 
nodular mass appearing to arise from the anterior abdominal 
wall in the left iliac fossa. Systemic examination revealed no 
significant finding.
Hematological investigations revealed neutrophilic 
leukocytosis with total leukocyte count of 15,000/mm3 and 
differential leukocyte count of 90% neutrophils, 08% lymphocytes, 
and 2% monocytes. Rest of the investigations including liver and 
renal function tests were within normal limits. Ultrasonography 
of lower abdomen revealed uterus and bilateral ovaries of normal 
size along with a large tumor on the left side. Contrast-enhanced 
computed tomography (CECT) findings of the abdomen were 
suggestive of suspected neoplastic mass most likely arising from 
left ovary and involving anterior wall with ipsilateral pelvic 
lymphadenopathy. A provisional diagnosis of ovarian neoplasm 
was made on the basis of CECT findings and patient was planned 
for surgery. Preoperatively serum cancer antigen-125 (CA) was 
252 U/ml.
Upon exploratory laparotomy, a hard nodular mass arising 
from the anterior abdominal wall was found in the region of left 
iliac fossa rather than from the left ovary. Primary cytoreductive 
surgery which included excision of abdominal wall mass, total 
abdominal hysterectomy with bilateral salpingo-oophorectomy 
and bilateral pelvic lymphadectomy was performed. On gross 
examination (Fig. 1), abdominal wall mass was hard, globular, and 
measured 15 × 13 × 4 cm. Outer surface was bosselated and showed 
congested blood vessels. On cut open, yellowish watery fluid 
oozed out. Cut surface showed a solid area measuring 10 × 8 cm 
along with multiple cystic spaces and numerous, soft, friable, 
grayish-white papillary excrescences. Wall thickness of the cystic 
spaces varied from 0.3 to 0.5 cm. Uterus and bilateral adnexa were 
of normal size and appeared uninvolved grossly. Representative 
sections were taken from formalin fixed specimen, processed as 
per routine protocol, stained with hematoxylin, and eosin stain; 
and observed microscopically. Relevant immunohistochemical 
stains were ordered for representative sections.
Microscopy of the abdominal mass showed a tumor composed 
of cells arranged in tubuloglandular, papillary, or occasionally in 
solid pattern with cells displaying high N:C ratio, pleomorphic 
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vesicular nuclei, prominent eosinophilic nucleoli, and clear to 
eosinophilic cytoplasm. A hobnail arrangement of the cells was 
also noted. Focal areas of necrosis and calcification were noted. 
5/10 HPF mitotic figures and apoptotic bodies were seen. Mild 
chronic inflammatory infiltrate was noticed in the surrounding 
connective tissue stroma (Figs. 2 and 3). Left external iliac lymph 
nodes (3/3) and left pelvic lymph nodes (6/8) showed metastatic 
deposits while right pelvic lymph nodes (0/5) were negative 
for tumor infiltration. Uterus and bilateral adenexa were free 
of tumor infiltration and showed no other significant finding. 
Based on the above described morphology, provisional diagnosis 
of PPCC was made with primary peritoneal serous carcinoma 
(PPSC) and malignant mesothelioma as closest differential 
diagnosis. Immunohistochemistry (IHC) confirmed the diagnosis 
of PPCC as the tumor cells were positive for cytokeratin-7 (CK), 
CA-125, epithelial membrane antigen, and vimentin and negative 
for estrogen receptors (ER), Wilm’s tumour-1 (WT-1), CK-20, 
CK-5/6, and calretinin (Figs. 4-6).
The immediate post-operative follow-up was uneventful with 
good recovery and following which the patient was discharged. 
Figure 1: Globular mass with bosselated outer surface
Figure 2: Papillary configuration and hobnail arrangement of cells
Figure 3: Cells displaying high N:C ratio, pleomorphic vesicular 
nucleus with prominent nucleolus and clear to eosinophilic cytoplasm
Figure 4: Immunostain for cytokeratin-7 (positive), inset - positive 
control
Figure 5: Immunostain for estrogen receptor (negative), inset - 
positive control
Figure 6: Immunostain for calretinin (negative), inset - positive 
control
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The patient was lost to further follow-up; however, interviewed 
telephonically the patient had received 6 cycles of chemotherapy 
(carboplatin and paclitaxel) every 3 weeks for 6 weeks. Post-
chemotherapy positron emission tomography/CECT did not 
reveal any residual tumor and the patient has not developed any 
other complaint since then.
DISCUSSION
PPCC is extremely rare, accounting for approximately 3% 
of primary peritoneal carcinomas, with an incidence of 
0.46/100,000 cases [2] and the first case to be reported among all 
the diagnosed malignant cases in the past 10 years at our institute, 
thus supporting the rarity of its occurrence. Most of the cases of 
PPCC reported till date have affected females in the age group of 
45-67 years, as also seen in the present case [1].
Abdominal distention and pain with or without ascites are the 
most frequently encountered clinical presentations [1]. Concurrent 
uterine pathologies reported in most of the cases were endometriosis, 
uterine adenocarcinoma, and endometrial hyperplasia [1]. In this 
case, no associated uterine pathology was identified. The diagnosis 
of primary peritoneal tumor is based on the gynecology oncology 
group criteria, originally described for primary adenocarcinoma 
of the peritoneum [3]. Diagnosis of PPCC is often difficult 
preoperatively and on routine histopathological examination,  as 
morphologically it closely resembles to malignant mesothelioma 
of peritoneum, PPSC, metastatic peritoneal carcinomatosis, and 
peritoneal psammocarcinoma [1].
Definitive diagnosis requires extensive IHC. Malignant 
mesothelioma can be differentiated from PPCC due to its 
positivity for calretinin and CK5/6, which are negative in 
PPCC [1]. Besides, mesothelioma has male preponderance and an 
associated history of long-term asbestos exposure, while PPCC 
has been mostly reported in females [4]. PPSC is typically positive 
for CK-7, ER, CA-125, and WT-1 [1]; thus, differentiating it 
from PPCC [1]. Peritoneal serous psammocarcinoma has more 
numerous psammoma bodies >80% of epithelial nests, less 
aggressive cytology, absent or moderate nuclear atypia, and rare 
mitosis as compared to PPCC [5]. PPCC are histologically similar 
to ovarian carcinomas and are believed to behave similarly [6]. 
Debulking  surgery and chemotherapy remains the mainstay of 
the treatment and radiotherapy appears to be effective in local 
control [6]. Mortality remains high in patients with PPCC, with a 
median survival of approximately 24 months and 5 years survival 
rate of 18% [7].
CONCLUSION
The current report presents a case of PPCC in a 55-year-old 
female. Due to its significant rarity, diagnostic challenges and 
sparsity of literature available on its biological behavior and 
treatment outcome, it is imperative to explore further,  various 
clinicopathological aspects of this rare tumor through long-
term follow-up of the patient to provide substantial information 
necessary for appropriate patient management.
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